Veserc 8 8 mg Tablet

    Veserc 8 8 mg

    Betahistine Dihydrochloride

    Category: Tablet

    Manufacturer: Unimed Unihealth Pharmaceuticals Ltd.

    Price: 27.01

    Strip

    Uses of Veserc 8: - Meniere's disease Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness. Phaeochromocytoma. Porphyria.
    Drugs used in meniere's diseases
    Betahistine acts as both partial histamine H1-receptor agonist and histamine H3-receptor antagonist in neuronal tissue. It improves the microcirculation in the labyrinth, thus reducing endolymphatic pressure.
    How to use Betahistine Dihydrochloride: Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Betahistine Dihydrochloride may be taken with or without food, but it is better to take it at a fixed time. Administration: Should be taken with food. Adult Dose: Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.
    May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.
    Phaeochromocytoma. Porphyria.
    Common - Headache - Nausea Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.
    Pregnancy: There is a very limited amount of data from the use of betahistine in pregnant women. Animal studies, though insufficient do not indicate direct or indirect harmful effects with respect to reproductive toxicity . As a precautionary measure, it is preferable to avoid the use of Betahistine during pregnancy. Lactation: There is insufficient information on the excretion of betahistine in human milk. Betahistine should not be used during breast-feeding.
    Precaution: Active peptic ulcer, bronchial asthma, pregnancy and lactation.
    Symptoms: Nausea, somnolence, abdominal pain, convulsion, pulmonary or cardiac complications. Management: Supportive treatment.
    Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
    Drugs used in meniere's diseases
    Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.
    In Pregnancy: The safety of Betahistine in human pregnancy has not been completely established, although there is no known teratogenic effect in animals. A careful assessment of potential benefits should be made before prescribing Betahistine in pregnancy.In Lactation: Betahistine is excreted in the breast milk of nursing mothers in concentrations similar to those found in plasma. Toxicity to the neonate at these concentrations is not known.
    Profile avater

    Samm Care